Enable Medicine

Micrographia Bio

This company develops AI-driven microscopy and spatial proteomics platforms to help drug developers and researchers visualise molecular interactions and identify therapeutic targets.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

PharmEnable

This company develops small molecule medicines using an artificial intelligence platform for pharmaceutical partners and patients with oncology and neurology conditions.

Immunai

Immunai develops an immune system mapping platform for biopharmaceutical companies to discover and optimise drug targets and clinical trials.

Nygen

This company develops cloud-based data platforms that use artificial intelligence to analyse and interpret single-cell genomic datasets for pharmaceutical and academic research teams.

Turing Biosystems

Turing Biosystems develops an interpretable artificial intelligence platform and graph database to help pharmaceutical companies and clinicians optimise therapies by analysing multi-omics data.

One Biosciences

One Biosciences develops an AI-powered single-cell transcriptomic platform to provide functional tumour profiling for oncologists and pharmaceutical companies.

Avicenna Biosciences

The company develops a machine learning platform to optimise small molecule drug discovery and lead-to-candidate processes for biotechnology and pharmaceutical organisations.